Cancer Early Detection Awareness And Prevention Of Breast Cancer

2160 Words 9 Pages
Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumour. Early breast cancer shows no symptoms or any pain, but as the cancer progresses, signs and symptoms can include a lump in or near the breast, also a change in the size, shape or tenderness.
An estimated 570,000 people living in the UK today have been diagnosed with breast cancer with over 50,000 are women and around 350 are men each year. Around 12,000 women and 80 men will die from breast cancer each year although when breast cancer is caught and treated at Stage 1, an early and localized stage, the 5-year survival rates are approximately 98% [1]
Our campaign will mostly be focusing on places in the community with
…show more content…
This service will be called Cancer Early Detection Awareness (CEDA) which will work in a similar fashion to the current successful MUR service provided by pharmacies. During CEDA, pharmacists will be prompted and made more aware of the risk factors relating to any cancer, more specifically in this case would be breast cancer. Having been prompted the pharmacist will be able to consult with the patient and highlight any particular risk factors such as age, family history and lifestyle. By creating this service we could reduce the pressure off the GP’s and increases the role of pharmacist to promote the current two week rule whereby patients who are suspected of cancer would be referred to a breast clinic for screening earlier than normal. Prior to undertaking CEDA, the patient needs to sign a consent form agreeing to the …show more content…
This specifically encourages more people to be aware of the signs and symptoms of breast cancer, allowing reduced prevalence of disease. The success of the awareness will be followed with up with NJS to compare previous statistics released 6 months after campaign. Another campaign outcome is to increase breast cancer screening appointments as a result this will decrease mortality rates and hospital admissions which in turn decrease healthcare costs. Data for this can be measured through feedback from GPs, hospitals and pharmacies. The decrease in death mortality and hospital admission can be measured via the NJS and Cancer Research Foundation. In addition, the decrease in healthcare costs is evaluated primarily through feedback from the NHS annual healthcare reports. A further outcome we hope to achieve is increased communication between patients and healthcare professionals especially pharmacists (HCPs) via CEDA. The success of CEDA will be demonstrated via annual records made by the

Related Documents

Related Topics